Understanding the Regulatory Landscape for Diagnostic Tests

RU Okay? Understanding the Regulatory Landscape for Diagnostic Tests in the US, UK and EU

Overview


Join us for an informative discussion on the evolving landscape of In Vitro Diagnostics (IVD) and Lab Developed Tests (LDTs). Our panel of industry leaders will delve into the latest developments from across the US, UK and Europe.

REGISTER

3:00 – 4:00 pm (GMT)
4:00 – 5:00 pm (CET)
10:00 – 11:00 am (EST)

Complimentary Webinar

Agenda


  • The FDA’s proposed rule on LDTs issued in September 2023 – what will this mean for test providers and manufacturers?
  • The landscape for Research Use Only and LDTs in the US, UK and Europe – what are the current exemptions?
  • EU IVDR timelines and extensions – the current transition and understanding when a change is significant
  • Compliance with the new standards – what do you need to know about clinical evidence and timelines to certification?
  • The UK IVD current landscape and the timelines for proposed new regulations – what flexibility is there?

Dig Deeper

New York, NY / McDermott Event / October 16, 2025

HPE NYC 2025

San Diego, California / McDermott Event / July 1, 2025

AHLA Annual Meeting Reception 2025

Frankfurt / McDermott Event / May 22, 2025

Private Equity Bootcamp 2025 in Frankfurt

Nashville, TN / McDermott Event / May 6-9, 2025

McDermott HealthEx

Webinar / McDermott Webinar / March 13 – April 24, 2025

Countdown to McDermott HealthEx: Webinar Preview Series

Paris, France / Speaking Engagements / April 10, 2025

GACS 2025 - Global Anticorruption & Compliance Summit